Climate change, human migration, and skin disease: is there a link?
Corresponding Author
Johannes F. Dayrit MD
De La Salle University Medical and Health Sciences Institute, Dasmarinas City, Philippines
Department of Dermatology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines
Correspondence
Johannes F. Dayrit, md
Department of Dermatology
Research Institute for Tropical Medicine
Alabang, Muntinlupa City 4118
Philippines
E-mail: [email protected]
Search for more papers by this authorAudi Sugiharto MD
Department of Dermatology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines
Search for more papers by this authorSarah J. Coates MD
Department of Dermatology, University of California San Francisco, San Francisco, CA, USA
Search for more papers by this authorDon Eliseo Lucero-Prisno III MD, PhD
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK
Search for more papers by this authorMark Denis D. Davis MD
Department of Dermatology, Mayo Clinic, Rochester, MN, USA
Search for more papers by this authorLouise K. Andersen MD
Department of Dermatology, Aleris-Hamlet Private Hospitals, Esbjerg, Denmark
Search for more papers by this authorCorresponding Author
Johannes F. Dayrit MD
De La Salle University Medical and Health Sciences Institute, Dasmarinas City, Philippines
Department of Dermatology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines
Correspondence
Johannes F. Dayrit, md
Department of Dermatology
Research Institute for Tropical Medicine
Alabang, Muntinlupa City 4118
Philippines
E-mail: [email protected]
Search for more papers by this authorAudi Sugiharto MD
Department of Dermatology, Research Institute for Tropical Medicine, Muntinlupa City, Philippines
Search for more papers by this authorSarah J. Coates MD
Department of Dermatology, University of California San Francisco, San Francisco, CA, USA
Search for more papers by this authorDon Eliseo Lucero-Prisno III MD, PhD
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, UK
Search for more papers by this authorMark Denis D. Davis MD
Department of Dermatology, Mayo Clinic, Rochester, MN, USA
Search for more papers by this authorLouise K. Andersen MD
Department of Dermatology, Aleris-Hamlet Private Hospitals, Esbjerg, Denmark
Search for more papers by this authorConflict of interest: None.
Funding source: National Cancer Institute, Fogarty International Center of the National Institutes of Health; D43TW009343, University of California Global Health Institute
Abstract
Climate change, exemplified by higher average global temperatures resulting in more frequent extreme weather events, has the potential to significantly impact human migration patterns and health. The consequences of environmental catastrophes further destabilize regions with pre-existing states of conflict due to social, political, and/or economic unrest. Migrants may carry diseases from their place of origin to their destinations and once there may be susceptible to diseases in which they had not been previously exposed to. Skin diseases are among the most commonly observed health conditions observed in migrant populations. To improve awareness among dermatologists of the burden of skin diseases among migrants, the group searched the English language scientific literature to identify articles linking climate change, migration, and skin disease. Skin diseases associated with human migration fall into three major categories: (i) communicable diseases, (ii) noncommunicable diseases, and (iii) environmentally mediated diseases. Adopting comprehensive global strategies to improve the health of migrants requires urgent attention.
References
- 1Kabir R, Khan H, Ball E, et al. Climate change impact: the experience of the coastal areas of Bangladesh affected by cyclones Sidr and Aila. J Env Public Health 2016; 2016: 9654753.
- 2Zimmerman C, Kiss L, Hossain M. Migration and health: a framework for 21st century policy-making. PLoS Med 2011; 8: e1001034.
- 3 IOM, WHO, UN. International migration, health and human rights. Int Migr Heal Hum Rights 2013; 1–60: https://doi.org/10.1037/e569712006-004
10.1037/e569712006?004 Google Scholar
- 4 International Organization for Migration. World Migration Report 2020; 2020.
- 5Raleigh C, Jordan L, Salehyan I. Assessing the impact of climate change on migration and conflict. World 2008; 24: 1–57. http://siteresources.worldbank.org/EXTSOCIALDEVELOPMENT/Resources/SDCCWorkingPaper_MigrationandConflict.pdf
- 6McMichael C. Climate change-related migration and infectious disease. Virulence 2015; 6: 548–553.
- 7Black R, Kniveton D, Skeldon R, et al. Demographics and climate change : future trends and their policy implications for migration. Int Organ 2008; 1–83. doi:migration; climate change.
- 8Berchin II, Valduga IB, Garcia J, et al. Climate change and forced migrations: An effort towards recognizing climate refugees. Geoforum 2017; 84: 147–150.
- 9Lundgren AD. Climate change and skin disease. Cutis 2018; 101: E12–E14.
- 10Hui Y, Thong H, Maibach HI. Global warming and its dermatologic impact. Expert Rev Dermatol 2011; 2014: 20–23.
- 11Kaffenberger BH, Shetlar D, Norton SA, et al. The effect of climate change on skin disease in North America. J Am Acad Dermatol 2016; 76: 140–147.
- 12Last JM. Global change: ozone depletion, greenhouse warming, and public health. Annu Rev Public Health 1993; 14: 115–136.
- 13Padovese V, Egidi AM, Fenech TM, et al. Migration and determinants of health: clinical epidemiological characteristics of migrants in Malta (2010–11). J Public Health 2014; 36: 368–374.
- 14Pavli A, Maltezou H. Health problems of newly arrived migrants and refugees in Europe. J Travel Med 2017; 24: 1–8.
- 15Nawas ZY, Tong Y, Kollipara R, et al. Emerging infectious diseases with cutaneous manifestations: viral and bacterial infections. J Am Acad Dermatol 2016; 75: 1–16.
- 16Botros BA, Watts DM, Soliman AK, et al. Serological evidence of dengue fever among refugees, Hargeysa, Somalia. J Med Virol 1989; 2: 79–81.
- 17Ahmed A, Elduma A, Magboul B, et al. The first outbreak of dengue fever in greater Darfur, Western Sudan. Trop Med Infect Dis 2019; 4: 43.
- 18Aguiar M, Stollenwerk N, Halstead SB. The impact of the newly licensed dengue vaccine in endemic countries. PLoS Negl Trop Dis 2016; 10: e0005179.
- 19Supadmi W, Suwantika AA, Perwitasari DA, et al. Economic evaluations of dengue vaccination in the Southeast Asia Region: evidence from a systematic review. Value Health Reg Issues 2019; 18: 132–144.
- 20Viennet E, Ritchie SA, Williams CR, et al. Public health responses to and challenges for the control of dengue transmission in high-income countries: four case studies. PLoS Negl Trop Dis 2016; 10: e0004943.
- 21Schmader K, Oxman M. Varicella and herpes zoster. In: L Goldsmith, S Katz, B Gilchrest, et al., eds. Fitzpatrick's Dermatology in General Medicine, 8th edn. New York: McGraw-Hill, 2012: 2386.
- 22de Valliere S, Cani N, Grossenbacher M, et al. Comparison of two strategies to prevent varicella outbreaks in housing facilities for asylum seekers. Int J Infect Dis 2011; 15: e716–e721.
- 23Lesens O, Baud O, Henquell C, et al. Varicella outbreak in Sudanese refugees from Calais. J Travel Med 2016; 23: 1–3.
- 24Di Meco E, Di Napoli A, Amato L, et al. Infectious and dermatological diseases among arriving migrants on the Italian coasts. Eur J Public Health 2018; 28: 910–916.
- 25Ramos JM, Romero D, Belinchón I. Epidemiology of leprosy in Spain: the role of the international migration. PLoS Negl Trop Dis. 2016; 10: 1–13.
- 26Yu R, Jarrett P, Holland D, et al. Leprosy in New Zealand: an epidemiological update. N Z Med J 2015; 128: 9–14.
- 27Lockwood D, Kumar B. Treatment of leprosy. The evidence base for newer drug combinations and shorter regimens is weak. BMJ 2004; 328: 1447–1448.
- 28Frankel A, Penrose C, Emer J. Cutaneous tuberculosis: a practical case report and review for the dermatologist. J Clin Aesthet Dermatol 2009; 2: 19–27.
- 29dos Santos JB, Figueiredo AR, Ferraz CE, et al. Cutaneous tuberculosis: epidemiologic, etiopathogenic and clinical aspects - Part I. An Bras Dermatol 2014; 89: 219–228.
- 30Pareek M, Greenaway C, Noori T, et al. The impact of migration on tuberculosis epidemiology and control in high-income countries: a review. BMC Med 2016; 14: 48.
- 31Gulisano G, Mariani L. Cutaneous tuberculosis: a rare presentation in an immigrant. J Travel Med 1998; 5: 131–134.
- 32Forgione P, Nunzi E, Cavalchini A, et al. [Scrofuloderma. a clinical case]. Minerva Pediatr 2004; 56: 119–122.
- 33Bagherirad M, Athan E, Harris OC. Forgotten but not gone - Scrofuloderma in a migrant student from India. Australas Med J 2013; 6: 371–373.
- 34Hargreaves S, Lonnroth K, Nellums LB, et al. Multidrug-resistant tuberculosis and migration to Europe. Clin Microbiol Infect 2017; 23: 141–146.
- 35Zouhair K, Akhdari N, Nejjam F, et al. Cutaneous tuberculosis in Morocco. Int J Infect Dis 2007; 11: 209–212.
- 36Piper Jenks N, Pardos de la Gandara M, D'Orazio BM, et al. Differences in prevalence of community-associated MRSA and MSSA among U.S. and non-U.S. born populations in Six New York Community Health Centers. Travel Med Infect Dis 2016; 14: 551–560.
- 37Manzur A, Dominguez AM, Pujol M, et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect 2008; 14: 377–380.
- 38Di RF, Leegaard TM, Moen EF, et al. MRSA infections in Norway: a study of the temporal evolution, 2006–2015. PLoS One 2017; 12: e0179771.
- 39Ravensbergen SJ, Berends M, Stienstra Y, et al. High prevalence of MRSA and ESBL among asylum seekers in the Netherlands. PLoS One 2017; 12: e0176481.
- 40Irvine J. Community-associated methicillin-resistant Staphylococcus aureus in Indigenous communities in Canada. Paediatr Child Health 2012; 17: 385–386.
- 41Lambert M. IDSA guidelines on the treatment of MRSA infections in adults and children. Am Fam Physician 2011; 84: 455–463.
- 42Magill SS, Manfredi L, Swiderski A, et al. Isolation of Trichophyton violaceum and Trichophyton soudanense in Baltimore, Maryland. J Clin Microbiol 2007; 45: 461–465.
- 43Maraki S, Mavromanolaki VE. Epidemiology of dermatophytoses in Crete, Greece. Med Mycol J 2016; 57: E69–E75.
- 44Mashiah J, Kutz A, Ben Ami R, et al. Tinea capitis outbreak among paediatric refugee population, an evolving healthcare challenge. Mycoses 2016; 59: 553–557.
- 45Mcpherson ME, Woodgyer AJ, Simpson K, et al. High prevalence of tinea capitis in newly arrived migrants at an English-language school, Melbourne, 2005. Med J Aust 2008; 189: 13–16.
- 46Mutch RC, Cherian S, Nemba K, et al. Tertiary paediatric refugee health clinic in Western Australia: analysis of the first 1026 children. J Paediatr Child Health 2012; 48: 582–587.
- 47Kolivras A, Lateur N, De Maubeuge J, et al. Tinea capitis in Brussels: epidemiology and new management strategy. Dermatology 2003; 206: 384–387.
- 48Markey RJ, Staat MA, Gerrety MJ, et al. Tinea capitis due to Trichophyton soudanense in Cincinnati, Ohio, in internationally adopted children from Liberia. Pediatr Dermatol 2003: 20: 408–410.
- 49Hay RJ. Tinea capitis: current status. Mycopathologia 2017; 182: 87–93.
- 50Antinori S, Gianelli E, Calattini S, et al. Cutaneous leishmaniasis: an increasing threat for travellers. Clin Microbiol Infect 2005; 11: 343–346.
- 51Handler MZ, Patel PA, Kapila R. Cutaneous and mucocutaneous leishmaniasis. J Am Dermatol 2015; 73: 897–908.
- 52Du R, Hotez PJ, Al-salem WS, et al. Old world cutaneous leishmaniasis and refugee crises in the Middle East and North Africa. PLoS Negl Trop Dis 2016; 10: e0004545.
- 53Inci R, Ozturk P, Mulayim MK, et al. Effect of the Syrian civil war on prevalence of cutaneous leishmaniasis in Southeastern Anatolia, Turkey. Med Sci Monit 2015; 21: 2100–2104.
- 54Saroufim M, Charafeddine K, Issa G, et al. Ongoing epidemic of cutaneous leishmaniasis among Syrian refugees, Lebanon. Emerg Infect Dis 2014; 20: 1712–1715.
- 55Kollipara R, Peranteau AJ, Nawas ZY, et al. Emerging infectious diseases with cutaneous manifestations: fungal, helminthic, protozoan and ectoparasitic infections. J Am Acad Dermatol 2016; 75: 19–30.
- 56Stark D, Van Hal S, Lee R, et al. Leishmaniasis, an emerging imported infection: report of 20 cases from Australia. J Travel Med 2008; 15: 351–354.
- 57Chandler DJ, Fuller LC. A review of scabies: an infestation more than skin deep. Dermatology 2019; 235: 79–80.
- 58Madke B, Khopkar U. Pediculosis capitis: an update. Indian J Dermatol Venereol Leprol 2012; 78: 429–438.
- 59Beeres DT, Ravensbergen SJ, Heidema A, et al. Efficacy of ivermectin mass-drug administration to control scabies in asylum seekers in the Netherlands: a retrospective cohort study between January 2014 – March 2016. PLoS Negl Trop Dis 2018; 12: e0006401.
- 60Engelman D, Cantey PT, Marks M, et al. Review The public health control of scabies: Priorities for research and action. Lancet 2019; 394: 81–92.
- 61Meister L, Ochsendorf F. Head lice - epidemiology, biology, diagnosis and treatment. Dtsch Arztebl Int 2016; 113: 763–772.
- 62McGraw TA, Turiansky GW. Cutaneous myiasis. J Am Acad Dermatol 2008; 58: 907–926.
- 63Lachish T, Marhoom E, Mumcuoglu KY, et al. Myiasis in travelers. J Travel Med 2015; 22: 232–236.
- 64Belda Hofheinz S, Guillén Martín S, Pérez Campos D, et al. Scalp myiasis in an immigrant child. An Pediatr 2003; 59: 114–116.
- 65Stauffer WM, Painter J, Mamo B, et al. Short report: Sexually transmitted infections in newly arrived refugees: is routine screening for Neisseria gonorrheae and Chlamydia trachomatis infection indicated? Am J Trop Med Hyg 2012; 86: 292–295.
- 66 Minnesota Department of Health. Sexually Transmitted Diseases, 2010. Published 2010. https://www.health.state.mn.us/diseases/reportable/dcn/sum10/std.html%0D
- 67 AIDSVu. HIV Local data: Minnesota. Published 2020. https://aidsvu.org/local-data/united-states/midwest/minnesota/
- 68Nyangoma EN, Olson CK, Painter JA, et al. Syphilis among U.S.-bound refugees, 2009-2013. J Immigr Minor Health 2017; 19: 835–842.
- 69 CDC. Sexually transmitted disease surveilance 2017. Published 2018. https://www.cdc.gov/std/stats17/natoverview.htm. Accessed July 6, 2019.
- 70Hernando V, Arco DA, Alejos B, et al. HIV infection in migrant populations in the European Union and European Economic Area in 2007–2012: An epidemic on the move. J Acquir Immune Defic Syndr 2018; 2015: 204–211.
- 71Eonomopoulou A, Pavli A, Stasinopoulou P, et al. Migrant screening: lessons learned from the migrant holding level at the Greek-Turkish borders. J Infect Public Health 2017; 10: 177–184.
- 72Tafuri S, Prato R, Martinelli D, et al. Prevalence of hepatitis B, C, HIV and syphilis markers among refugees in Bari, Italy. BMC Infect Dis 2010; 10: 213.
- 73Dias S, Marques A, Gama A, et al. HIV Risky sexual behaviors and HIV infection among immigrants: a cross-sectional study in Lisbon, Portugal. Int J Environ Res Public Health 2014; 11: 8552–8566.
- 74Clark RC, Mytton J. Estimating infectious disease in UK asylum seekers and refugees: a systematic review of prevalence studies. J Public Health 2007; 29: 420–428.
- 75Tschachler E. The dermatologist and the HIV/AIDS pandemic. Clin Dermatol 2014; 32: 286–289.
- 76Morrone A. Dermatologists and venereologists discuss refugee crisis. EADV Symposium. Published 2016. https://healthcare-in-europe.com/en/news/dermatologists-venereologists-discuss-refugee-crisis.html
- 77Cabieses B, Uphoff E, Pinart M, et al. A systematic review on the development of asthma and allergic diseases in relation to international immigration: the leading role of the environment confirmed. PLoS One 2014; 9: e0105347.
- 78Wohl Y, Wainstein J, Bar-Dayan Y. Atopic dermatitis in Israeli adolescents—a large retrospective cohort study. Acta Derm Venereol 2014; 94: 695–698.
- 79Silverberg JI, Simpson EL, Durkin HG, et al. Prevalence of allergic disease in foreign-born American children. JAMA Pediatr 2013; 167: 554–560.
- 80Elfaituri SS. Skin diseases among internally displaced Tawerghans living in camps in Benghazi, Libya. Int J Dermatol 2016; 55: 1000–1004.
- 81Cheng HM, Kumarasinghe SP. Dermatological problems of asylum seekers arriving on boats: a case report from Australia and a brief review. Australas J Dermatol 2014; 55: 270–274.
- 82Brufman T, Ben-Ami R, Mizrahi M, et al. Mycetoma of the foot caused by madurella mycetomatis in immigrants from sudan. Isr Med Assoc J 2015; 17: 418–420.
- 83Relhan V, Mahajan K, Agarwal P, et al. Mycetoma: an update. Indian J Dermatol 2017; 62: 332.
- 84Ternavasio-De La Vega HG, Angel-Moreno A, Hernández-Cabrera M, et al. Skin and soft tissue infections (Patera Foot) in immigrants, Spain. Emerg Infect Dis 2009; 15: 598–600.
- 85Martinez O, Wu E, Sandfort T, et al. Evaluating the impact of immigration policies on health status among undocumented immigrants: a systematic review Omar. J Immigr Minor Health 2016; 17: 947–970.
- 86 Migration and health: key issues. WHO Reg Off Eur.
- 87Saikal S, Ge L, Mir A, et al. Skin disease profile of Syrian refugees in Jordan: a field-mission assessment. J Eur Acad Dermatol Venereol 2019; 34: 419–425.